Trial intelligence / Profile preview

Dinalbuphine Sebacate for postoperative pain in complex spine surgery

TCTR20250617002Phase 3Recruiting

Sponsor
Faculty of Medicine Siriraj Hospital, Mahidol University
Start
Dec 2025
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of dinalbuphine sebacate in postoperative pain, sponsored by Faculty of Medicine Siriraj Hospital, Mahidol University. Started Dec 2025; status: recruiting.

02

Drugs

dinalbuphine sebacate
03

Conditions

postoperative pain

Beyond the preview

Go deeper on TCTR20250617002.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20250617002.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call